Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Philips (NYSE: PHG) has announced a collaboration with Tend, a leading dental practice network, to offer Philips Zoom! whitening treatments across Tend's national network of dental offices. The partnership introduces Philips Zoom! WhiteSpeed, the #1 patient-requested professional whitening brand in the U.S., which combines hydrogen peroxide and advanced blue LED light technology.
The treatment is clinically proven to whiten teeth up to eight shades in 45 minutes, offering fast results with minimal sensitivity for most patients. The advanced blue LED light technology enhances the whitening process by targeting stain components that hydrogen peroxide alone cannot reach, ensuring safe and consistent results.
Philips (NYSE: PHG) has significantly improved its position on Forbes' 'Canada's Best Employers 2025' list, advancing more than 160 spots from the previous year. The health technology leader secured the second position in the Healthcare Equipment & Services Category, marking its second consecutive year on the prestigious ranking.
The Forbes list, now in its 10th edition, features 300 top organizations across various industries in Canada. The selection process involved an independent survey of over 40,000 Canada-based employees from companies with at least 500 employees, considering more than 900,000 employer evaluations.
Els Vandecandelaere, Head of People at Philips North America, attributed this achievement to the company's employees, highlighting their passion for improving lives and commitment to delivering impact through patient care, people, and environmental consciousness.
Bridgefield Capital has entered into a definitive agreement to acquire Philips Emergency Care Business from Royal Philips N.V. (NYSE: PHG). The transaction, expected to close in 2025, will be executed through Emergency Care Holdings, targeting the $26 billion emergency medical products market.
The Philips Emergency Care Business operates in over 130 countries with more than 3 million installed Automated External Defibrillators (AEDs) and Advanced Life Support devices, supported by 480 global distribution partners. The business holds the #1 globally recognized brand in the AED market, pioneering biphasic waveform AEDs in the late 1990s.
The business addresses sudden cardiac arrest, which causes over 4.25 million deaths annually. Its product portfolio includes AEDs for public and home use, Tempus monitor-defibrillators for EMS services, and DFM 100 manual defibrillators for hospitals, complemented by advanced informatics solutions for device readiness and data management.
Philips (NYSE: PHG) has announced two key executive appointments effective January 1, 2025. Jie Xue has been appointed as Chief Business Leader Precision Diagnosis and co-leader of the Diagnosis & Treatment segment, joining from GE Healthcare where she served as President and CEO of Global Magnetic Resonance Imaging. Özlem Fidanci has been named Chief of International Region, joining from Versuni after a previous 22-year career at Philips.
Both executives will join Philips' Executive Committee, reporting directly to CEO Roy Jakobs. Xue replaces Bert van Meurs, who was temporarily leading Precision Diagnosis and will continue to lead Philips' Image Guided Therapy business. Fidanci succeeds Edwin Paalvast, who is retiring after five years at Philips.
Northeast Florida Healthy Start Coalition (NEFHSC), Baptist Health, and Philips Avent have partnered to provide a free one-year subscription to the premium version of Pregnancy+ app for families in Baker, Clay, and Duval counties. The app, ranked #1 worldwide for pregnancy, offers personalized content, expert information, and 3D models to track baby development.
The premium version includes videos and audio courses with maternal health experts, connecting users to community resources like home visiting programs. The initiative aims to improve birth outcomes and reduce infant mortality. Similar implementation in Michigan has reached 32,000 residents and connected 1,000 Medicaid-eligible individuals to evidence-based home visiting programs.
Philips and Mayo Clinic announced a research collaboration to advance cardiac MRI technology through AI integration. The partnership aims to reduce complex MRI exam times and improve workflow efficiency by combining proprietary AI technologies from both organizations. The research will evaluate lower-field-strength MRI solutions to expand access for patients with metallic implants and explore ways to make cardiac MRI more accessible. With ischemic heart disease being the leading cause of global mortality and costing $252.2 billion in the U.S. (2021), this initiative targets improved patient care and broader MRI accessibility.
Philips has unveiled enhanced AI capabilities for its CT 5300 system at RSNA 2024, featuring the CT Smart Workflow with AI-enabled 'Precise' software solutions. The system combines the NanoPanel Precise detector with ultra-low noise reconstruction technology, offering up to 50% improved positioning accuracy, 70% better user consistency, and 23% reduced positioning time. The technology enables 80% lower radiation dose, 85% lower noise, and 60% improved low-contrast detectability.
Additionally, Philips announced a collaboration with Annalise.ai to evaluate Critical Care AI integration for emergency department triage, which has shown to improve report turnaround times by up to 39%.
Philips unveiled new AI-powered diagnostic and treatment imaging innovations at RSNA 2024, focusing on addressing radiologist challenges amid increasing patient volumes and staff shortages. The company introduced the industry's first wide-bore, high-performance helium-free MR scanner with cloud-based AI capabilities, and the AI-enabled CT 5300 featuring Precise Image reconstruction software. The Spectral CT 7500 has demonstrated up to 97% diagnostic sensitivity compared to 55% with conventional CT. Philips also expanded its collaboration with AWS to offer integrated diagnostics portfolio in the cloud, including radiology, digital pathology, and cardiology solutions.
Philips has expanded its strategic collaboration with Amazon Web Services (AWS) to offer cloud-based integrated diagnostics solutions. The partnership aims to unify diagnostic workflows across radiology, digital pathology, cardiology, and AI advanced visualization. Over 150 sites in North and Latin America have already transitioned to Philips HealthSuite Imaging on AWS, with plans to expand to Europe.
The collaboration leverages AWS's cloud capabilities and generative AI to enhance clinical workflows, offering remote access to diagnostic tools and unified patient data views. Philips is developing AI applications using Amazon Bedrock's foundation models, focusing on features like conversational reporting to improve efficiency and reduce administrative burdens.
Philips and icometrix have partnered to deploy an AI-driven solution for MRI brain scan analysis, focusing on Alzheimer's and multiple sclerosis diagnosis. The solution integrates icometrix's FDA-cleared quantitative brain software into Philips' BlueSeal MR scanners and healthcare informatics platform. The collaboration addresses the growing demand for neurological imaging, particularly with new Alzheimer's treatments requiring multiple MRI scans. The integrated system features icobrain ARIA software for monitoring treatment side effects and icobrain ms for MS diagnosis, offering automated quantitative measurements and improved diagnostic accuracy.